These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
453 related items for PubMed ID: 24578213
1. Targeting angiogenesis in squamous non-small cell lung cancer. Piperdi B, Merla A, Perez-Soler R. Drugs; 2014 Mar; 74(4):403-13. PubMed ID: 24578213 [Abstract] [Full Text] [Related]
6. Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung. Pajares MJ, Agorreta J, Larrayoz M, Vesin A, Ezponda T, Zudaire I, Torre W, Lozano MD, Brambilla E, Brambilla C, Wistuba II, Behrens C, Timsit JF, Pio R, Field JK, Montuenga LM. J Clin Oncol; 2012 Apr 01; 30(10):1129-36. PubMed ID: 22355056 [Abstract] [Full Text] [Related]
10. Therapeutic options targeting angiogenesis in nonsmall cell lung cancer. Crinò L, Metro G. Eur Respir Rev; 2014 Mar 01; 23(131):79-91. PubMed ID: 24591665 [Abstract] [Full Text] [Related]
11. Vascular endothelial growth factor receptor as target for advanced non-small cell lung cancer therapy. Rossi A, Maione P, Sacco PC, Ambrosio R, Falanga M, Gridelli C. Curr Drug Targets; 2010 Jul 01; 11(7):865-8784. PubMed ID: 20412044 [Abstract] [Full Text] [Related]
12. Angiogenesis inhibitors and vascular disrupting agents in non-small cell lung cancer. Rossi A, Maione P, Ferrara ML, Sacco PC, Schettino C, Bareschino MA, Gridelli C. Curr Med Chem; 2009 Jul 01; 16(30):3919-30. PubMed ID: 19747132 [Abstract] [Full Text] [Related]
13. Targeting angiogenesis for treatment of NSCLC brain metastases. Schettino C, Bareschino MA, Rossi A, Maione P, Sacco PC, Colantuoni G, Rossi E, Gridelli C. Curr Cancer Drug Targets; 2012 Mar 01; 12(3):289-99. PubMed ID: 22229249 [Abstract] [Full Text] [Related]
14. Anti-Angiogenics: Their Value in Lung Cancer Therapy. Janning M, Loges S. Oncol Res Treat; 2018 Mar 01; 41(4):172-180. PubMed ID: 29631257 [Abstract] [Full Text] [Related]
16. Inhibition of angiogenesis in the treatment of non-small cell lung cancer. Keedy VL, Sandler AB. Cancer Sci; 2007 Dec 01; 98(12):1825-30. PubMed ID: 17892508 [Abstract] [Full Text] [Related]
19. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival. Decaussin M, Sartelet H, Robert C, Moro D, Claraz C, Brambilla C, Brambilla E. J Pathol; 1999 Aug 01; 188(4):369-77. PubMed ID: 10440746 [Abstract] [Full Text] [Related]
20. Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer. Zhang X, Wang Y, Fan J, Chen W, Luan J, Mei X, Wang S, Li Y, Ye L, Li S, Tian W, Yin K, Ju D. J Immunother Cancer; 2019 Dec 11; 7(1):346. PubMed ID: 31829270 [Abstract] [Full Text] [Related] Page: [Next] [New Search]